BRCA2 and ovarian cancer: BRCA1 and BRCA2 genes had highest frequency of PVs among patients with ovarian cancer (5.4% in BRCA1 and 4% in BRCA2) followed by patients with breast cancer (2.1% in BRCA1 and 1.7% in BRCA2).